4954
E. Colacino et al. / Tetrahedron Letters 49 (2008) 4953–4955
O
Ts
Br
K2CO3
O
X
O
N
DABCO
H
Ti(O-i-Pr)4
+
+
Ts NH2
i-PrOH
MS 4 A
9 h, r.t.
Grubbs II
CH2Cl2
NO2
O
DMF
NO2
NO2
20 h, r.t.
12 h, r.t.
1
2
3
4a X = TsNH 51%
5 83%
+
Ts
NO2
4b X = OH
38%
N
O
6 86%
N
N
N
O
HN
NO2
NO2
t
-BuOK
DMF
0ºC
2.5 h
CH3I
H2 / Pd-C
H2 / Pd-C
Cs2CO3
N
N
O
DMF
MeOH
MeOH
12 h, r.t.
O
12 h, r.t.
12 h, r.t.
10 38%
9 82%
8 98%
7 47%
Scheme 1. Synthesis of 4-ethyl-1-methyl-1H-pyrrolo-[3,2-c]quinoline N-oxide 9.
performed either at room temperature within 12 h or under micro-
wave irradiation at 100 °C for only 10 min without affecting the
yield. After purification by chromatography, diene 5 was subse-
quently submitted to the ring closing metathesis (RCM) reaction
known to be an efficient method for the synthesis of heterocyclic
structures from linear precursors.18–21 Cyclization of diene 5 bring-
ing to the novel conjugated cyclic enone 6 was complete within
12 h at room temperature using 5% 2nd generation air stable Grub-
bs’ catalyst in good yield. Attempts to accelerate the reaction by
microwave (100 °C, CH2Cl2)16 were unsuccessful, due to degrada-
tion of the starting material.
10 (Scheme 1). The last compound was recovered by column chro-
matography in a moderate yield, along with traces of the corre-
sponding amine.
In conclusion, an efficient synthesis of 2-substituted-3-keto-
pyrrole has been developed, through a sequential aza-BH/ring clos-
ing metathesis/aromatization as a novel route to access to a novel
hexacyclic nitrone, after palladium-catalyzed reductive cyclization.
A deoxygenation reaction provides also an easy conversion into the
imine. Biological tests are in progress to evaluate the full potential
of the novel structure presented here.
Few examples for the formation of 3-carboxy-substituted five
membered heterocyclic alkenes through RCM reaction22–26 are
reported, as well as their synthesis starting from aza-BH
adducts,11,16,17,27,28 but none of them focus on the synthesis of
2-aryl-3-keto-substituted pyrrole according to this procedure.
The next step was cleavage of the tosyl group.29–31 Using t-
BuOK in DMF at room temperature, 47% of the substituted pyrrole
7 was obtained within 2.5 h via elimination/aromatization steps.
We supposed that the moderate yield resulted from the isomeriza-
tion of pyrroline, or to secondary reactions involving the enol form
of ketone. Then, pyrrole 7 was reacted with methyl iodide32 in the
presence of Cs2CO3 in DMF to yield the corresponding methylated
pyrrole 8 in high yield. Similar structures, in which a methyl group
is used to protect pyrrole ring, have been synthesized to afford very
potent antiviral, antibacterial and anticancer agents.33,34 Directly
used without any purification, methyl-protected pyrrole 8 was
hydrogenated at room temperature in methanol using Pd/C under
H2 atmosphere,35 yielding a very polar compound, which was iden-
tified as the stable hitherto unknown 4-ethyl-1-methyl-1H-pyrrol-
o-[3,2-c]quinoline N-oxide 936 with the nitrone function confined
to a ring structure in good yield, after purification by column chro-
matography. The conversion was not quantitative and 16% of the
starting material was still present in the mixture, as determined
by 1H NMR of the crude. The synthesis of differently substituted
quinoline N-oxides has been described starting from the Baylis–
Hillman adduct of o-nitrobenzaldehyde: in acidic medium, to
access penta-37 or hexa-cyclic38,39 nitrones, or through an hydroge-
nation/cyclization cascade reaction,40 but no examples are
reported for pyrrolo-quinoline N-oxide structures.
Acknowledgements
We thank the CNRS and la Ligue contre le Cancer for financial
support.
References and notes
1. Merino, P. Science of Synthesis; Padwa, A., Ed.; Thieme: Stuttgart, 2004; Vol. 27,
pp 511–580.
2. Pyne, S. G.; Minyan, T. Curr. Org. Chem. 2005, 9, 1393–1418.
3. Andreev, V. P.; Korvacheva, E. G.; Nizhnik, Y. P. Pharm. Chem. J. 2006, 40, 347–
348.
4. Capraro, H.-G.; Furet, P.; Garcia-Echeverria, C.; Stauffer, F.; WO 2005054238,
2005, p 138.
5. Albrecht, T.; Spleelman, D. J.; Sadagopa Ramanujam, V. M.; Lund, H. W.;
Legator, M. S.; Trieff, N. M. Terat. Carcin. Mut. 1980, 1, 161–169.
6. Werbel, L. M.; Kersten, S. J.; Turner, W. R. Eur. J. Med. Chem. 1993, 28, 837–
852.
7. Mouaddib, A.; Joseph, J.; Hasnaoui, A.; Mérour, Y.-J. Synthesis 2000, 4, 549–556.
8. Zhang, H.; Joseph, J.; Vasquez-Vivar, J.; Karoui, H.; Nsanzumuhire, C.; Martàsek,
P.; Tordo, P.; Kalyanaraman, B. FEBS Lett. 2000, 473, 58–62.
9. Floyd, R. A. Aging Cell 2006, 5, 51–57.
10. Green, A. R.; Ashwood, T.; Odergren, T.; Jackson, D. M. Pharmacol. Ther. 2003,
100, 195–214.
11. (a) Declerck, V.; Allouchi, H.; Martinez, J.; Lamaty, F. J. Org. Chem. 2007, 72,
1518–1521; (b) Benakki, H.; Colacino, E.; André, C.; Guenoun, F.; Martinez, J.;
Lamaty, F. Tetrahedron 2008, 64, 5949–5955.
12. Varray, S.; Gauzy, C.; Lamaty, F.; Lazaro, R.; Martinez, J. J. Org. Chem. 2000, 65,
6787–6790.
13. Varray, S.; Lazaro, R.; Martinez, J.; Lamaty, F. Eur. J. Org. Chem. 2002, 2308–
2316.
14. Varray, S.; Lazaro, R.; Martinez, J.; Lamaty, F. Organometallics 2003, 22, 2426–
2435.
15. Shi, Y.-L.; Shi, M. Eur. J. Org. Chem. 2007, 2905–2916.
16. Declerck, V.; Ribière, P.; Martinez, J.; Lamaty, F. J. Org. Chem. 2004, 69, 8372–
8381.
17. Balan, D.; Adolfsson, H. Tetrahedron Lett. 2004, 45, 3089–3092.
18. Deiters, A.; Martin, S. F. Chem. Rev. 2004, 104, 2199–2238.
19. Felpin, F.-X.; Lebreton, J. Eur. J. Org. Chem. 2003, 3693–3712.
When the hydrogenation reaction was prolonged for more than
12 h, N–O hydrogenolysis/deoxygenation process occurred and a
side reaction involving pyrrolo-quinoline N-oxide 9 yielded imine